>> 全站文章索引 >> 第21页:
  • 脑白质变化可能是抑郁症的首要标志 - [.]
  • 双相障碍诊断率在上升 - [.]
  • 初级抑郁干预护理会减少死亡 - [.]
  • 精神分裂症阴性症状在使用SSRIs后未改善 - [.]
  • 临床流行病学首发精神病1年结果以及预测因素 - [.]
  • 广泛性焦虑症：一项40年的跟踪研究 - [.]
  • 抗抑郁剂治疗的依从性以及社会心理因素和临床因素对老年抑郁症患者治疗结局的影响 - [.]
  • 治疗首发精神分裂症的新一代抗精神病药 - [.]
  • 治疗抑郁症：米氮平和其他抗抑郁剂的比较 - [.]
  • 米氮平对抑郁合并其他障碍的年长患者生活健康质量的影响 - [.]
  • 米氮平对于有慢性头痛的患者的作用：资料回顾性研究 - [.]
  • 米氮平与帕罗西汀治疗惊恐障碍的比较：一项开放性的研究 - [.]
  • Developing an intervention for depressed, chronically medically ill elders: a model from COPD - [George S. Alexopoulos, Patrick J. Raue, Jo Anne Sirey, Patricia A. Arean]
  • Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder - [K. Pennington, C L. Beasley, P. Dicker, A. Fagan, J. English, C M. Pariante]
  • Hypomanic symptoms predict an increase in narcissistic and histrionic personality disorder features in suicidal young adults - [Golan Shahar, Ph.D., Margaret-Ann Scotti, B.Sc. M. David Rudd]
  • 在初级保健机构中，焦虑、抑郁和疼痛之间的关系 - [Adrienne J. Means-Christensen, Ph.D., Peter P. Roy-Byrne, M.D]
  • A specific attentional bias in panic disorder - [Klara De Cort, M.Sc., Dirk Hermans, Ph.D. , Adriaan Spruyt, Ph.D. , Eric Griez]
  • Sex differences in symptom patterns of recurrent major depression in siblings - [Valentina Moskvina, Ph.D. , Anne Farmer, M.D., M.R.C.Psych.]
  • Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications - [Peter M. Haddad1, Sonu G. Sharma]
  • Developmental expression profile of quaking, a candidate gene for schizophrenia - [Tara L. Lauriat, Lily Shiue , Vahram Haroutunian , Miguel Verbitsky]
  • The CATIE Schizophrenia Trial: Results, Impact, Controversy - [Theo C. Manschreck Roger A. Boshes]
  • Longitudinal Trajectories of Depression and Anxiety in a Prospective Community Study - [Kathleen Ries Merikangas, PhD; Heping Zhang, PhD; Shelli Avenevoli]
  • Somatic Symptoms and Physiologic Responses in Generalized Anxiety Disorder and Panic Disorder - [Hoehn-Saric R, McLeod DR, Funderburk F, Kowalski P]
  • Stable Prediction of Mood and Anxiety Disorders Based on Behavioral and Emotional Problems in Childhood - [Roza SJ, Hofstra MB, van der Ende J, Verhulst FC]
  • Complicated Grief as a Disorder Distinct From Bereavement-Related Depression and Anxiety: A Replication Study - [HG Prigerson, AJ Bierhals, SV Kasl, CF Reynolds 3rd, MK Shear]
  • The Empirical Basis of Generalized Anxiety Disorder - [Brown TA, Barlow DH, Liebowitz MR]
  • Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder - [Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, Shea MT, Keller MB]
  • A Family Study of Generalized Anxiety Disorder - [R Noyes Jr, C Clarkson, RR Crowe, WR Yates and CM McChesney]
  • 社区癌症成年患者与非癌症患者疼痛、抑郁及疲劳发病情况的调查 - [Cielito C. Reyes-Gibby, DrPH, Lu Ann Aday, PhD, Karen O. Anderson, PhD,Tito R. Mendoza, PhD, and Cha]
  • 抑郁症和癌症：发病机制和疾病进展 - [David Spiegel and Janine Giese-Davis]
  • Antidepressant drugs in the treatment of anxiety disorders - [Allan Scott, Alan Davidson and Karen Palmer]
  • Effect of Comorbid Anxiety Disorders on the Hypothalamic-Pituitary-AdrenalAxis Response to a Social Stressorin Major Depression - [E. Young, J. Abelson, O. Cameron]
  • Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists - [Weisberg RB, Dyck I, Culpepper L, Keller MB]
  • A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety Disorders - [Hettema JM, Neale MC, Kendler KS]
  • Neurobiological Mechanisms of Social Anxiety Disorder - [Mathew SJ, Coplan JD, Gorman JM]
  • Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia - [Etkin A, Wager TD]
  • Brief cognitive-behavioural therapies versus other brief psychological therapies for depression - [R Churchill, V Hunot, R Corney, M Knapp, H McGuire, A Tylee, S Wessely]
  • Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder - [KA Macritchie, JR Geddes, J Scott, DR Haslam, GM Goodwin]
  • The myelin-pathogenesis puzzle in schizophrenia: a literature review - [G. Karoutzou, H M. Emrich, D E. Dietrich, Professor Dr DE Dietrich]
  • 回顾简短的服药依从性的工具，对精神分裂症患者和双相障碍患者 - [Brian Pomykacz; Melissa Mao; Roger D. Weiss; Christian J. Teter]
  • 抑郁、焦虑和疼痛对晚期癌症患者心理的影响 - [.]
  • 儿童癌症患者的突破性疼痛 - [.]
  • Prevalence and symptomatology of depression in older people living in institutions in England and Wales - [F. A. McDougall,F. E. Matthews, K. Kvaal, M. E. Dewey3 and C. Brayne]
  • What do general medical guidelines say about depression care? Depression treatment recommendations in general medical practice guidelines - [Kilbourne, Amy Ma,b; Daugherty, Brandic; Pincus, Harold Aland]
  • New directions in the conceptualization of psychotic disorders - [Kroll, Jerome L]
  • Depression and anxiety in obstructive sleep apnea syndrome: a review - [T. Saunamäki, M. Jehkonen1]
  • Physical illness and schizophrenia: a review of the literature - [S. Leucht1, T. Burkard1, J. Henderson2, M. Maj3, N. Sartorius4]
  • Co-occurrence patterns of anxiety, depression and alcohol use disorders - [Naomar Almeida-Filho1, Ines Lessa2, Lucélia Magalhães2, Maria Jenny Araújo2, Estela Aquino2 and Jair]
  • The case for cothymia: mixed anxiety and depression as a single diagnosis PETER TYRER - [.]
  • The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care - [Hirschfeld RM]
  • Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease - [Shorter E, Tyrer P]
  • Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review - [Mirza I, Jenkins R]
  • Psychiatric and Somatic Markers of Anxiety: Identification and Pharmacologic Treatment - [Gelenberg AJ]
  • The DSM-IV field trial for mixed anxiety-depression - [Zinbarg RE, Barlow DH, Liebowitz M, Street L, Broadhead E, Katon W, Roy-Byrne P, Lepine JP, Teherani]
  • 综合性医疗中早期停用抗抑郁药：病人和处方医师的特点与关系 - [Hansen DG, Vach W, Rosholm JU]
  • Duloxetine, 60 mg once daily, for major depressive: disorder a randomized double-blind placebo-controlled trial - [Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA]
  • Pharmacokinetics and Safety of Duloxetine,a Dual-Serotonin and Norepinephrine Reuptake Inhibitor - [Sharma A, Goldberg MJ, Cerimele BJ]
  • 男性精神分裂症的患病风险明显高于女性 - [.]
  • 米氮平口服崩解片比较文拉法辛缓释剂：双盲、随机和多中心研究，比较抗抑郁剂治疗抑郁症患者的起效作用 - [Benkert O, Szegedi A, Philipp M]
  • 抗精神病药物很少被应用在具有精神病学特征的重性抑郁症的治疗 - [.]
  • 社交焦虑和失眠：抑郁症状的调节作用 - [Buckner JD, Bernert RA, Cromer KR, Joiner TE, Schmidt NB]
  • 创伤后应激障碍(PTSD)睡眠紊乱的流行病学特征、影响因素和治疗措施 - [Maher MJ, Rego SA, Asnis GM]
  • 抑郁症和心血管疾病风险：系统综述和荟萃分析 - [Van der Kooy K, van Hout H, Marwijk H]
  • 神经衰弱和抑郁症的谱性研究：过程，稳定性和转变 - [Gamma A, Angst J, Ajdacic V]
  • 睡眠生理测定条件下米氮平和氟西汀对抑郁伴有失眠病人的疗效比较 - [Winokur A, DeMartinis NA, McNally DP]
  • 综合性医疗中早期停用抗抑郁药：病人和处方医师的特点与关系 - [Hansen DG, Vach W, Rosholm JU]
  • 米氮平在国内的临床试验综述 - [郭慧荣|任玉明]
  • 米氮平与帕罗西汀治疗老年抑郁症的对照研究 - [张杰文|郭慧荣]
  • 男性精神分裂症的患病风险明显高于女性 - [.]
  • 社交焦虑和失眠：抑郁症状的调节作用 - [Buckner JD, Bernert RA, Cromer KR, Joiner TE, Schmidt NB]
  • 创伤后应激障碍(PTSD)睡眠紊乱的流行病学特征、影响因素和治疗措施 - [Maher MJ, Rego SA, Asnis GM]
  • 神经衰弱和抑郁症的谱性研究：过程，稳定性和转变 - [Gamma A, Angst J, Ajdacic V]
  • Placebo interventions for all clinical conditions - [A Hróbjartsson, PC Gøtzsche]
  • Aripiprazole versus typicals for schizophrenia - [J Bhattacharjee, HGG El-Sayeh]
  • Gilbert's syndrome in a patient with predominantly negative symptoms of schizophrenia - [Andrew J. Powell ; Lars K. Hansen]
  • Common and Specific Dimensions of Self-Reported Anxiety and Depression in Adolescent Outpatients - [Robert A. Steer, David A. Clark, Geetha Kumar ,Aaron T. Beck]
  • Cat odour-induced anxiety—a study of the involvement of the endocannabinoid system - [Silva Sütt, Sirli Raud,Tarmo Areda, Ain Reimets, Sulev Kõks1,Eero Vasar]
  • Is depression a risk factor for heart complaints? : Longitudinal aspects in the Zurich study - [Dominique Eich, Christoph Neuhaus, Alex Gamma, Jules Angst]
  • The Maudsley early onset schizophrenia study : Predictors of psychosocial outcome at 4-year follow-up - [Nora S. Vyas, Michael Hadjulis, Apostolos Vourdas, Patrick Byrne , Sophia Frangou]
  • The DISC locus in psychiatric illness - [J E. Chubb, N J. Bradshaw, D C. Soares, D J. Porteous, J K. Millar, Dr KJ Millar]
  • Temporal lobe and “default” hemodynamic brain modes discriminate between schizophrenia and bipolar disorder - [Vince D. Calhoun , Paul K. Maciejewski , Godfrey D. Pearlson, Kent A. Kiehl]
  • Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study - [Agnès Soudry, Carole Dufouil ,Karen Ritchie ,Jean-François Dartigues]
  • The long term — Maximising potential for rehabilitation in patients with schizophrenia - [Andrea Fagiolini, Arianna Goracci]
  • Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results - [Josep Maria Haro, David Suarez, Diego Novick, Jacqueline Brown]
  • Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia - [Eiji Shimizu, Masao Imai, Mihisa Fujisaki, Naoyuki Shinoda, Satoshi Handa]
  • Low dosage tricyclic antidepressants for depression - [T Furukawa, H McGuire, C Barbui]
  • Amisulpride versus other atypical antipsychotics for schizophrenia - [K Komossa, C Rummel, H Hunger, F Schmidt, S Schwarz, JIS Mota Neto, S Leucht]
  • Schizophrenia with prominent catatonic features (‘catatonic schizophrenia ’).II. Factor analysis of the catatonic syndrome - [Gabor S. Ungvari,William Goggins, Siu-Kau Leung ,Jozsef Gerevich]
  • Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone - [José Manuel Montes ,Jose Luis Rodriguez, Eduardo Balbo, Pedro Sopelana]
  • Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients - [Michael Segala,Avi Avitalc,Severina Berstein]
  • Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations - [Sylvain Grignon,Jean Marc Chianetta]
  • Heterogeneity of Treatment Effects in Schizophrenia - [T. Scott Stroup MD, MPH]
  • Basal ganglia volumes in drug-naive first-episode schizophrenia patients before - [Andreas Glenthoj,Birte Y.Glenthoj,Torben Mackeprang,Anne K.Pagsberg]
  • What do symptoms mean - [.]
  • What Are the Right Targets for Psychopharmacology - [Hyman SE, Fenton WS]
  • "Unexplained" somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift - [Sharpe M, Carson A]
  • Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks - [Galea S, Vlahov D, Resnick H, Ahern J, Susser E, Gold J, Bucuvalas M, Kilpatrick D]
  • Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians - [Simon GE, Von Korff M, Rutter CM, Peterson DA]
  • The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide - [Gibbons RD, Hur K, Bhaumik DK, Mann JJ]
  • The Relationship Between Antidepressant Medication Use and Rate of Suicide - [Gibbons RD, Hur K, Bhaumik DK, Mann JJ]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 28 29 30